Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2021-08-12
Product name
LAMIVUDINE TABLETS 150 & 300 MG
Product Synonyms
3TC * 3TC-OTC * 3TC TABLETS-ATM * EPIVIR-ATM * EPIVIR 3TC * LAMIVUDINE 150 & 300 MG
1.2.2. Uses advised against
No other uses are advised
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
ViiV Healthcare Limited
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Section 2
Physical hazards
Not classified.
Health hazards
Reproductive toxicity Category 2 Specific target organ toxicity following Category 2 repeated exposure
Environmental hazards
Not classified.
Signal word
Warning
Hazard statements
Suspected of damaging fertility or the unborn child. May cause damage to organs through prolonged or repeated exposure.
Prevention
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Do not breathe dust/fume/gas/mist/vapours/spray. Wear protective gloves/protective clothing/eye protection/face protection.
Response
IF exposed or concerned: Get medical advice/attention.
Storage
Store locked up.
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations.
Other hazards which do not result in classification
Assume that this material is capable of sustaining combustion. Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
Additional information
48.5 % of the mixture consists of component(s) of unknown acute oral toxicity. 100 % of the mixture consists of component(s) of unknown acute dermal toxicity. 51.5 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 51.5 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.